(NGH) Quote

tim ord
most stuff baked in
summer fall pb should start soon
https://www.youtube.com/watch?v=wtZTkpd7oTo

Thanks for the alert in at 4.30 gap at 28$ lol

Correct.

Ha! Your posts have mini value!

Actually No split✅Dividend🟩+$5MBuyback🟩+$HCWC+ $HCMC has a 4-point plan


-A buyback of up to $5M of $HCMC common stock.

-A spinoff of certain HCMC assets into a new publicly traded company

-A stock dividend to $HCMC sharehold

Thanks!

$3K profit is fine for me

$NVVE 7.49

Cintas price target raised to $225 from $212.50 at Truist
Truist raised the firm's price target on Cintas to $225 from $212.50 and keeps a Buy rating on the shares ahead of the company's Q1 results next week. The firm anticipates another earnings beat against a more difficult comp due to work

Your posts are extremely poor, someone needs to give you an upgrade. It's like you are living in the past, like a dial up phone connection, and you just can't get on line.

$NVVE 6.72

Share cancellation a big factor? How so?

This reminds me of dryships lol

On CDF possibility. Instead, LP told you more than you thought at the June 2024 ASM. She discussed “health economic modeling.” To me that means they are much further along than you suspect.

https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appra

$OMEX all out at .95XX's in at .56 AVG -- not bad for a few hours trade..

at leat we have a leaderboard working....no tv

PRTG: Don't blink.

About time ;-)

https://www.sciencedirect.com/science/article/abs/pii/S1524904224002297

Got ya! Buy high sell low

They claim it's an ammo depot they hit.

Weren't certain cheerleaders claiming there wasn't going to be any dilution? Wasn't Xavier also claiming there wasn't going to be any dilution this year......or was it this month?😂

Don't be surprised to see a reverse split in the future.

https://mailchi.mp/niocorp.com/niocorp-looks-to-potentially-recycle-post-consumer-rare-earth-magnets-and-produce-made-in-usa-heavy-rare-earths-in-nebraska?e=a8db996c82

Being among the first to gain approval for generic OxyContin could give Elite an advantage in a competitive generic drug market. It would demonstrate Elite's capabilities in formulating complex extended-release medications and potentially abuse-deterrent formulations. A successful launch could posit

I said this over a week ago....
Aren't you special!